Utilizing a novel technology called Particle Replication In Non-Wetting Templates (PRINT) platform, Liquidia is developing rationally designed carriers for improved delivery of small molecule and biological cargos. Liquidia
The initiative follows a formal pre-NDA verification with the FDA that verified the results from Tarsa’s Phase III ORACAL trial and the requirements for regulatory approval. The Phase
The funds will be used for the preclinical development of m102.4, an antibody indicated as a post-exposure prophylactic against Nipah or Hendra virus infection, that can lead to
Both the companies hope to make use of their resources to promote vital university clinical development. The agreement will make use of IntelliCell’s expertise in separation of adipose
The deal covers the production of MoxDuo Capsules, which will be supplied in the US market through 2015 and an immediate-release Dual Opioid pain therapy containing morphine and
The company has upgraded its existing operating system with centralized web-based application for its growing supply chain organization. Maestro is believed to have a flexible architecture which allows
INC424, an oral inhibitor of the JAK1 and JAK2 tyrosine kinases, is being evaluated in primary myelofibrosis as well as post-polycythemia vera myelofibrosis (PPV-MF), post-essential thrombocythemia myelofibrosis (PET-MF),
MM-121 is a fully human monoclonal antibody that targets ErbB3. The study is intended to assess the safety and pharmacokinetics of MM-121 when administered in combination with cetuximab
CETP inhibition is believed to potentially raise HDL (good cholesterol) levels and help prevent cardiovascular disease. As per the deal, Simcere will receive exclusive rights to develop and
Ths system will be used as a centralized Customer Relationship Management (CRM) platform by UCB Nordics for Specialty, Market Access and Key Account Management (KAM) commercial teams throughout
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.